Research article · 2015
Conference abstractPublished 24 Jun 2014
A preclinical overview on gold (III) compounds in the forefront of the targeted anticancer therapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
I n the last four decades the drug cisplatin has been widely used in oncology despite of its toxicity, in particular nephrotoxicity, due to the high affinity of the soft metal center Pt(II) toward renal sulfur- and selenium-containing enzymes, thus affecting their catalytic processes. Taking into account the severe toxicological profile of cisplatin and the peculiar chemical properties of Pt (II), a number of metal compounds with encouraging antitumor activity and reduced toxicity compared to the reference drug have been recently designed, synthetized and biologically studied. In designing these coordination compounds, we replaced the Pt(II) and the two ammonia ligands were replaced with Au(III), Cu(II) or Ru (III) and a dithiocarbamato (DTC) moiety, respectively. Among all the studied complexes, our Au (III)-based potential chemotherapeutics showed a particularly promising chemotherapeutic index. On the other hand, the bidentate DTC ligand is able to widely stabilize metal ions owing to its electron-donating capability, thus hindering the ligand-metal decomposition that could give rise to non-specific metal reactivity in healthy tissues. Furthermore, the presence of sulfur donor atoms in the DTC ligand prevents the metal from interacting with thiol-containing biomolecules (trans effect), resulting in reduced or even absent side-toxicity. So far, researches on gold(III)-dithiocarbamato derivatives of aminoacids and oligopeptides have been carried out. These compounds generally showed higher antitumor activity than cisplatin and no cross-resistance to the reference drug on several human tumor cell lines. In vivo studies, on breast cancer MDA-MB-231 and prostate cancer PC3 xenografts, showed a reduction of 53% and 70% in tumor volume respectively, with neither decreased activity nor weight loss. The in vivo acute toxicity by i.v. and oral administration routes recording remarkable results. No signs of toxicity have been observed during the study in any of the treated animals. It is worth highlighting that body weight for any mouse was constant or increased during the 14-day observation period. Along with the antiblastic activity against breast cancer, a transcriptomic study has been performed to yield a deep mechanistic understanding of what biochemical pathways, crosstalks and feedbacks are affected by our gold(III) compounds
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 21 Sep 2018
Exo-III assisted amplification strategy through target recycling of Hg2+ detection in water: A gold nanoparticle-based label-free colorimetry employing T-rich hairpin-loop metallobase
Short communication · 28 May 2021
Insight into Mechanism of Action of Anticancer Bicyclic Compounds
Conference abstract · 29 Nov 2011
Autologous tendon progenitor cells therapy for treatment of tendinopathy: From preclinical to clinical trial
Conference abstract · 29 Nov 2011
Saffron: A potential target for a novel anticancer drug against hepatocellular carcinoma
More from this journal
The newest in Journal of Cell Science & Therapy.
Perspective · 2 Feb 2026
Exploring Senescence and Its Influence on Tissue Function and Therapeutic Research
Commentary · 2 Feb 2026
Metabolism Regulation and Its Influence on Therapeutic Development in Human Disease
Commentary · 2 Dec 2025
Cellular Membranes and Transport Proteins as Regulators of Homeostasis and Metabolic Coordination
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cell Science & Therapy
- SubjectBiology
- BylineArticles whose byline prints “Chiara Nardon”
- BylineArticles whose byline prints “Leonardo Brustolin”
- BylineArticles whose byline prints “Mauro Coluccia”
- BylineArticles whose byline prints “D Fregona”

